Chemours (NYSE:CC) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.07 by 26.47 percent. This is a 54.55 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $1.300 billion which missed the analyst consensus estimate of $1.328 billion by 2.14 percent. This is a 4.34 percent decrease over sales of $1.359 billion the same period last year.